Roche seeks FDA approval for new cervical cancer test | July 12, 2013 | Pleasanton Weekly | PleasantonWeekly.com |


https://pleasantonweekly.com/print/story/print/2013/07/12/roche-seeks-fda-approval-for-new-cervical-cancer-test


Pleasanton Weekly

- July 12, 2013

Roche seeks FDA approval for new cervical cancer test

Expanded indication would allow biotech firm's Cobas Test to take lead in cervical screening strategy

by Jeb Bing

Roche, one of the world's largest biotech companies with operations in Pleasanton's Hacienda Business Park, has submitted a request to the U.S. Food and Drug Administration (FDA) seeking the addition of a cervical cancer primary screening indication for the Cobas HPV Test.

This story contains 282 words.

Stories older than 90 days are available only to subscribing members. Please help sustain quality local journalism by becoming a subscribing member today.

If you are already a subscriber, please log in so you can continue to enjoy unlimited access to stories and archives. Subscriptions start at $5 per month and may be cancelled at any time.

Log in     Subscribe